Drug class
Butyrophenone antipsychotic; serotonin 5-HT2A and dopamine-receptor antagonist
Mechanism of action
Binds mainly to 5-HT2A receptors, with high affinity for D4 and moderate affinity for D2/D3 and other receptors. Its antipsychotic activity reflects modulation of central serotonergic and dopaminergic signalling.
General use cases
- Treatment of schizophrenia and selected chronic psychotic disorders in countries where pipamperone is authorised.
- Symptomatic management of selected behavioural disturbances or aggression where covered by local product information.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
